Structure (Chemicalstructure)
Mesalamine Tablet, Delayed Release
Product Images NDC 72162-2213
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 72162-2213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl721622213)
This text appears to be the description of a medication called Mesalamine Delayed-Release Tablets. Each tablet contains 1.2 grams of Mesalamine, which is a USP ingredient. The tablets are meant to be taken once daily. It is important to keep the medication out of the reach of children. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be dispensed in a tightly sealed and light-resistant container. The pharmacist is instructed to dispense the patient package inserts. The NDC number is 72162-2213-2. The medication is manufactured by Haimen Pharma Inc., and it has been relabeled by Bryant Ranch Prepack, Inc. Unfortunately, there is no readable information available about the specific medical conditions this medication is used for or any associated precautions or side effects.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
